Micro Emerging Active

La désignation Fast Track de la FDA pour Climb Bio

New narrative with limited coverage — still forming.

Score
0,5
Vélocité
▲ 1,0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Avr 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
Avr 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

Articles Liés

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · Avr 24, 2026
Mixed

Chronologie

Dernière mise à jourAvr 22, 2026